Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ICON is a world-leading clinical research organization (CRO) providing outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device industries. The company specializes in the strategic development, management, and analysis of programs that support all phases of the clinical development process, from compound selection to Phase I-IV clinical studies. Headquartered in Dublin, Ireland, ICON operates a global network of offices and employs over 41,000 people across more than 50 countries. In 2021, the company significantly expanded its scale and capabilities through the $12 billion acquisition of PRA Health Sciences. ICON is recognized for its expertise in adaptive trial designs, decentralized clinical trials, and comprehensive clinical laboratory services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Icon Clinical.